A multi-center phase II study of docetaxel plus cisplatin as first-line therapy in patients with metastatic squamous cell esophageal cancer.

Saved in:
Bibliographic Details
Title: A multi-center phase II study of docetaxel plus cisplatin as first-line therapy in patients with metastatic squamous cell esophageal cancer.
Authors: Kim JY (AUTHOR), Do YR (AUTHOR), Park KU (AUTHOR), Kim MK (AUTHOR), Lee KH (AUTHOR), Bae SH (AUTHOR), Ryoo HM (AUTHOR), Baek JH (AUTHOR), Song HS (AUTHOR)
Source: Cancer Chemotherapy & Pharmacology. 2010 May, Vol. 66 Issue 1, p31-36. 6p.
Database: Academic Search Ultimate
Description
ISSN:03445704
DOI:10.1007/s00280-009-1130-6